Literature DB >> 16632342

Brain cancer stem-like cells.

Toru Kondo1.   

Abstract

Both stem cells and cancer cells are thought to be capable of unlimited proliferation. Moreover, many tumours and cancer cell lines express stem cell markers, including adenosine triphosphate (ATP)-binding cassette transporters, by which the cells pump out specific fluorescent dyes as well as anti-cancer drugs, suggesting either that cancer cells resemble stem cells or that cancers contain stem-like cells. Using the common characteristics of brain tumour cells and neural stem cells, several research groups have succeeded in identifying stem-like cells (cancer stem-like cells) in brain tumours and brain cancer cell lines. The purified cancer stem-like cells, but not the other cancer cells, self-renew and form tumours when transplanted in vivo. Thus, cancer stem-like cells in brain tumours might be a crucial target for anti-brain tumour therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16632342     DOI: 10.1016/j.ejca.2006.01.038

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

1.  Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth.

Authors:  Marie E Beckner; Esther P Jane; Brian Jankowitz; Naomi R Agostino; Kevin A Walter; Ronald L Hamilton; Ian F Pollack
Journal:  Cancer Lett       Date:  2007-05-31       Impact factor: 8.679

2.  Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.

Authors:  M F Shi; J Jiao; W G Lu; F Ye; D Ma; Q G Dong; X Xie
Journal:  Cell Mol Life Sci       Date:  2010-06-12       Impact factor: 9.261

3.  Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.

Authors:  Zhiwei Wang; Yiwei Li; Dejuan Kong; Sanjeev Banerjee; Aamir Ahmad; Asfar Sohail Azmi; Shadan Ali; James L Abbruzzese; Gary E Gallick; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

4.  Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells.

Authors:  Smile Echizenya; Yukiko Ishii; Satoshi Kitazawa; Tadashi Tanaka; Shun Matsuda; Eriko Watanabe; Masao Umekawa; Shunsuke Terasaka; Kiyohiro Houkin; Tomohisa Hatta; Tohru Natsume; Yoshimasa Maeda; Shin-Ichi Watanabe; Shinji Hagiwara; Toru Kondo
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

5.  The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.

Authors:  Luci Bavaresco; Andressa Bernardi; Elizandra Braganhol; Angélica Regina Cappellari; Liliana Rockenbach; Patrícia Fernandes Farias; Márcia Rosângela Wink; Andrés Delgado-Cañedo; Ana Maria Oliveira Battastini
Journal:  Mol Cell Biochem       Date:  2008-07-18       Impact factor: 3.396

6.  Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.

Authors:  Virginie Clément-Schatlo; Denis Marino; Karim Burkhardt; Patrick Teta; Fabienne Leyvraz; Bawarjan Schatlo; Stephan Frank; Karl Schaller; Vincent Castella; Ivan Radovanovic
Journal:  Neuro Oncol       Date:  2012-05-14       Impact factor: 12.300

7.  Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.

Authors:  Hyangsoon Noh; Qingnan Zhao; Jun Yan; Ling-Yuan Kong; Konrad Gabrusiewicz; Sungguan Hong; Xueqing Xia; Amy B Heimberger; Shulin Li
Journal:  Cancer Lett       Date:  2018-07-06       Impact factor: 8.679

8.  Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the niche.

Authors:  Felipe de Almeida Sassi; Algemir Lunardi Brunetto; Gilberto Schwartsmann; Rafael Roesler; Ana Lucia Abujamra
Journal:  J Oncol       Date:  2012-07-08       Impact factor: 4.375

9.  A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics.

Authors:  Donglai Lv; Shi-Cang Yu; Yi-Fang Ping; Haibo Wu; Xilong Zhao; Huarong Zhang; Youhong Cui; Bing Chen; Xia Zhang; Jianwu Dai; Xiu-Wu Bian; Xiao-Hong Yao
Journal:  Oncotarget       Date:  2016-08-30

10.  Exosomal miR-155-5p derived from glioma stem-like cells promotes mesenchymal transition via targeting ACOT12.

Authors:  Zixu Bao; Ning Zhang; Wanxiang Niu; Maolin Mu; Xiaoming Zhang; Shanshan Hu; Chaoshi Niu
Journal:  Cell Death Dis       Date:  2022-08-19       Impact factor: 9.685

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.